Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

por Immisch, Lena, Papafotiou, George, Popp, Oliver, Mertins, Philipp, Blankenstein, Thomas, Willimsky, Gerald
Publicado 2023

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma

por Immisch, Lena, Papafotiou, George, Popp, Oliver, Mertins, Philipp, Blankenstein, Thomas, Willimsky, Gerald
Publicado 2022

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors

por Immisch, Lena, Papafotiou, George, Gallarín Delgado, Nerea, Scheuplein, Vivian, Paschen, Annette, Blankenstein, Thomas, Willimsky, Gerald
Publicado 2023

In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo

por Willimsky, Gerald, Beier, Christin, Immisch, Lena, Papafotiou, George, Scheuplein, Vivian, Goede, Andrean, Holzhütter, Hermann-Georg, Blankenstein, Thomas, Kloetzel, Peter M
Publicado 2021